Lower Urinary Tract Dysfunction Database

Neurogenic Bladder Clinical Trial

Official title:

Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01293110
• Other study ID #: KEK-2010-0207/0/PB_2016-0189
• Status: Recruiting
• Start date: January 2010
• Est. completion date: January 2030

Study information

• Verified date: May 2024
• Source: University of Zurich
• Contact: Thomas M Kessler, MD
• Phone: +41 44 386 39 07
• Email: thomas.kessler[@]balgrist.ch
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with neurological disease/injury often suffer from lower urinary tract symptoms, which frequently have a negative impact on the patients' health related quality of life. The prevalence of lower urinary tract dysfunction is high and the treatment is a challenge because available treatments may fail. In this study data of patients with lower urinary tract dysfunction treated at the University of Zürich, are prospectively and systematically collected in a database.

Description:

Lower urinary tract dysfunction is characterized by detrusor overactivity, detrusor sphincter dyssynergia, voiding dysfunction, stress incontinence, or a combination of these and frequently has a negative impact on the patients' health related quality of life. In addition, the treatment of lower urinary tract dysfunction is a challenge because conventional therapies may fail. Adequate treatment and long-term follow-up of lower urinary tract dysfunction is important to achieve/maintain continence and preserve renal function. Thus, we aim to prospectively collect clinical, video-urodynamic and radiological data of patients with neurogenic lower urinary tract dysfunction treated at the University of Zürich in a database.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 7000
• Est. completion date: January 2030
• Est. primary completion date: January 2030
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• patient of Balgrist University Hospital

• patient of University Hospital Zürich

• urodynamic examination

• written informed consent

Exclusion Criteria:

• no written informed consent

Related Conditions & MeSH terms

• Diseases of the Lower Urinary Tract: General Conditions
• Neurogenic Bladder
• Urinary Bladder, Neurogenic

Locations

Country	Name	City	State
Switzerland	Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital	Zürich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survival of the patients		first visit to death